Key takeaways
Sunosi is a controlled substance used for treating excessive daytime sleepiness in people with narcolepsy or obstructive sleep apnea.
For different reasons, such as cost, side effects, or inadequate symptom management, some people may need to switch to alternative treatments.
Common alternatives to Sunosi include Nuvigil (armodafinil) and Provigil (modafinil), which are typically less expensive.
Healthcare providers prescribe medications like Sunosi to promote wakefulness for adults with narcolepsy. It’s also prescribed for people with obstructive sleep apnea (OSA) who are experiencing excessive daytime sleepiness despite continuous positive airway pressure (CPAP) therapy. Sunosi works by increasing the activity of two important brain chemicals, dopamine and norepinephrine, which promote alertness and wakefulness and increase energy.
However, currently only brand-name Sunosi is available in the U.S., though a generic was approved in June 2026. This means it can be expensive for most people, as brand-name medications are often costly. Luckily, less pricey alternatives are available. Your healthcare provider may also recommend switching to a medication such as Nuvigil (armodafinil) or Provigil (modafinil) if you experience side effects on Sunosi. Keep reading to learn more about your options.
What can I take instead of Sunosi?
Commonly prescribed alternatives to Sunosi include Provigil (modafinil), Nuvigil (armodafinil), Wakix (pitolisant), and Xywav. “All are legitimate, established options,” says Adam Mednick, MD, PhD, a board-certified neurologist and author of Normal Pressure Hydrocephalus. “In head-to-head studies, Sunosi tends to rank at or near the top for reducing sleepiness, but modafinil, armodafinil, and Wakix all produce meaningful improvement,” he says.
Sunosi alternatives compared |
||
|---|---|---|
| Medication | Controlled substance? | Key notes |
| Provigil (modafinil) | Yes (Schedule IV) | It is approved for improving wakefulness in adults with OSA, narcolepsy, or shift work disorder. However, it is not indicated for treating the underlying cause of OSA. |
| Nuvigil (armodafinil) | Yes (Schedule IV) | It has similar indications to modafinil.
Dr. Mednick notes that both armodafinil and modafinil are older, generic wake-promoting agents that are widely used and generally well tolerated. However, they can interact with other drugs, including reducing the effectiveness of hormonal birth control. |
| Wakix (pitolisant) | No | Specifically approved for treating cataplexy and excessive daytime sleepiness (EDS) in people with narcolepsy aged 6 years and older.
According to Dr. Mednick, it often ranks best for safety and has a favorable cardiovascular safety profile that may make it a good option for people with underlying heart disease. |
| Xywav | Yes (Schedule III) | Xywav is only available through a central pharmacy and is prescribed by physicians with special certification.
“Xywav is taken at night, acts differently from the other agents by improving nighttime sleep, and uniquely treats both cataplexy and daytime sleepiness in narcolepsy as well as idiopathic hypersomnia,” Dr. Mednick says. |
Other alternatives that may be prescribed include traditional stimulants such as Ritalin (methylphenidate), Adderall (amphetamine), and Dexedrine (dextroamphetamine).
Paul Gross MD, a primary care physician and medical doctor at LIV3 Health, notes that while all of these drugs can play a role in managing excessive daytime sleepiness, they are not always interchangeable, which is why a provider should assess you before you make a switch.
“Wake-promoting agents (modafinil & armodafinil) act as such; pitolisant acts by activating histaminergic neurons; and Xywav is administered and indicated for different reasons and carries different risk factors than the others,” Dr. Gross says. The drug of choice will depend on a person’s diagnosis, symptoms, tolerance to medication, and past medical history.
Save up to 80% on Sunosi with SingleCare
Different pharmacies offer different prices for the same medication. SingleCare helps find the best price for you.
Why might a healthcare provider switch you from Sunosi?
There are different reasons why a healthcare provider may switch you from Sunosi:
- Side effects: “Some people may experience side effects, including headache, nausea, decreased appetite, anxiety, insomnia, irritability, and dry mouth,” says Dr. Mednick. In this case, their provider may recommend switching to a different medication.
- Inadequate symptom management: According to Dr. Gross, a healthcare provider might consider switching you to another medication if Sunosi doesn’t create significant improvements in wakefulness during the day.
- Other underlying medical conditions: Because Sunosi is a controlled substance that can raise blood pressure and heart rate, a healthcare provider may avoid it for individuals with hypertension or heart disease. Dr. Mednick also notes that it requires caution or dose adjustment in chronic kidney disease.
- Cost and insurance coverage: Affordability is also a valid reason why a healthcare provider may suggest an alternative. A Sunosi generic was approved, but is not yet available, so the brand-name medication can carry a high retail price. Also, not all insurance plans may cover Sunosi.
“Switching is common and can be done safely with guidance from a provider familiar with this medication. Any change should include a plan to manage daytime sleepiness during the transition and to monitor for new side effects from alternative treatments,” Dr. Mednick says.
How do the alternatives compare in cost?
Generic versions of alternatives like modafinil and armodafinil are widely available at lower cost than Sunosi. However, if Sunosi is the best option for you, you can save with a SingleCare coupon. Depending on the pharmacy you choose, a SingleCare coupon can get you a 30-day supply of Sunosi 150 mg tablets for $808 instead of the average retail price of about $1,270.
Sunosi alternatives cost comparison |
||
|---|---|---|
| Medication | Average retail price | Lowest SingleCare price |
| Sunosi | $1,275 per 30, 150 mg tablets | $808 |
| Provigil (modafinil) | $3,211 for 30, 200 mg tablets for brand-name Provigil and $905 for generic modafinil | $22 for generic modafinil |
| Nuvigil (armodafinil) | $1,338 for 30, 250 mg tablets for brand-name Nuvigil and $623 for generic armodafinil | $32 for generic armodafinil |
| Wakix (pitolisant) | This is a limited-availability drug and is not available at most pharmacies. Consider contacting your insurance company about its availability. | Not available |
Frequently asked questions
Is there a generic version of Sunosi?
A generic version of Sunosi was approved in June 2026. However, it is not expected to be available in the U.S. until 2040.
Will insurance cover modafinil or armodafinil instead of Sunosi?
Health insurance plans are more likely to cover modafinil and armodafinil than Sunosi because they are older medications available in generic versions, which means they cost less. However, coverage varies by plan. You can check your plan’s formulary, which lists the drugs your health insurance plan covers, to see whether it covers Sunosi.
Can I switch from Sunosi to another wakefulness medication on my own?
You should not switch from Sunosi to another alternative wakefulness-promoting medication on your own. Switching should be done only when your healthcare provider has carefully assessed you and recommended an appropriate replacement depending on factors, such as your symptoms, your concerns, and how well you tolerated the current medication. Any change in medication will require a new prescription from your healthcare provider.
The SingleCare prices in this article are the most accurate at the time of publishing in ZIP code 23666 as of Sep. 24, 2026. Prices vary by pharmacy. Visit our coupon page for updated drug prices at pharmacies near you.
- Comparative efficacy and safety of multiple wake-promoting agents for the treatment of residual sleepiness in obstructive sleep apnea despite continuous positive airway pressure: A systematic review and network meta-analysis of randomized controlled trials, CNS Drugs (2025)
- Sunosi, Sunosi official prescribing site (2026)
- A comprehensive review of solriamfetol to treat excessive daytime sleepiness, Psychopharmacology Bulletin (2024)
- About Sunosi, Sunosi official prescribing site (2026)
- Dopamine and noradrenaline in the brain; Overlapping or dissociate functions?, Frontiers in Molecular Neuroscience (2020)
- Treating people who have idiopathic hypersomnia or narcolepsy, Hypersomnia Foundation
- Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: A retrospective analysis of the FAERS database, Frontiers in Pharmacology (2024)
- Possible Sunosi side effects, Sunosi official prescribing site (2026)
- Xywav, Xywav official site (2026)
- Pitolisant: A review in narcolepsy with or without cataplexy, CNS Drugs (2020)
- Armodafinil tablet, National Library of Medicine: DailyMed (2023)
- Modafinil, an atypical CNS stimulant? Advances in Pharmacology (2024)
- Modafinil tablet, National Library of Medicine: DailyMed (2021)
- Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea, Journal of Clinical Sleep Medicine (2021)
Expert Contacts
- Adam Mednick, MD, PhD, a board-certified neurologist and author of Normal Pressure Hydrocephalus: From Diagnosis to Treatment.
- Paul Gross MD, a primary care physician at LIV3 Health.
- Medically accurate: SingleCare’s Medical Review Board analyzes all of our content to confirm it’s in line with current medical advice.
- Evidence-based: Our content is sourced from reputable U.S.-based healthcare professionals and peer-reviewed research.
- Trustworthy: All of SingleCare’s content goes through a multi-phase review process by our writers, editors, and Medical Board in order to provide clear and credible information.